Fieldcure
Seoul, KR · 1 known investors
FieldCure develops iMET, an electric field-based cancer therapy device that applies alternating electric fields at specific frequencies to disrupt mitosis in cancer cells while sparing normal cells. The system includes 64-channel electrode control and an AI-based treatment planning system for patient-specific optimization, targeting intractable cancers such as pancreatic cancer.
Founders & leadership
MY
Myung-Geun YoonCEO
Investors · 1
Frequently asked questions
- What does Fieldcure do?
- FieldCure develops iMET, an electric field-based cancer therapy device that applies alternating electric fields at specific frequencies to disrupt mitosis in cancer cells while sparing normal cells. The system includes 64-channel electrode control and an AI-based treatment planning system for patient-specific optimization, targeting intractable cancers such as pancreatic cancer.
- Who founded Fieldcure?
- Fieldcure was founded by Myung-Geun Yoon.
- Who are Fieldcure's investors?
- Fieldcure's investors include Aju IB Invesment Corporation.
- Where is Fieldcure headquartered?
- Fieldcure is headquartered in Seoul, KR.